Literature DB >> 26774582

Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3σ protein-protein interactions.

Daniela Valensin1, Ylenia Cau1, Pierpaolo Calandro1, Giulia Vignaroli1, Lucia Dello Iacono1, Mario Chiariello2, Mattia Mori3, Maurizio Botta4.   

Abstract

BV02 is a reference inhibitor of 14-3-3 protein-protein interactions, which is currently used as chemical biology tool to understand the role of 14-3-3 proteins in pathological contexts. Due to chemical instability in certain conditions, its bioactive form has remained unclear. Here, we use NMR spectroscopy to prove for the first time the direct interaction between the molecule and 14-3-3σ, and to depict its bioactive form, namely the phthalimide derivative 9. Our work provides molecular insights to the bioactive form of the 14-3-3 PPI inhibitor and facilitates further development as candidate therapeutic agent.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  14-3-3; Bioactive form; Chemical instability; Chemical transformation; Drug discovery; Lead compound; NMR

Mesh:

Substances:

Year:  2015        PMID: 26774582     DOI: 10.1016/j.bmcl.2015.12.066

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Modulators of 14-3-3 Protein-Protein Interactions.

Authors:  Loes M Stevers; Eline Sijbesma; Maurizio Botta; Carol MacKintosh; Tomas Obsil; Isabelle Landrieu; Ylenia Cau; Andrew J Wilson; Anna Karawajczyk; Jan Eickhoff; Jeremy Davis; Michael Hann; Gavin O'Mahony; Richard G Doveston; Luc Brunsveld; Christian Ottmann
Journal:  J Med Chem       Date:  2017-10-19       Impact factor: 7.446

2.  Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61.

Authors:  Andrea Calcaterra; Valentina Iovine; Bruno Botta; Deborah Quaglio; Ilaria D'Acquarica; Alessia Ciogli; Antonia Iazzetti; Romina Alfonsi; Ludovica Lospinoso Severini; Paola Infante; Lucia Di Marcotullio; Mattia Mori; Francesca Ghirga
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

3.  Structure-based assessment and network analysis of targeting 14-3-3 proteins in prostate cancer.

Authors:  Alex Root; Azadeh Beizaei; H Alexander Ebhardt
Journal:  Mol Cancer       Date:  2018-10-31       Impact factor: 27.401

4.  Chemically stable inhibitors of 14-3-3 protein-protein interactions derived from BV02.

Authors:  Leire Iralde-Lorente; Ylenia Cau; Letizia Clementi; Lorenzo Franci; Giusy Tassone; Daniela Valensin; Mattia Mori; Adriano Angelucci; Mario Chiariello; Maurizio Botta
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.